Early 18F-FDG PET/CT Evaluation Shows Heterogeneous Metabolic Responses to Anti-EGFR Therapy in Patients with Metastatic Colorectal Cancer.
Erik J van HeldenOtto S HoekstraRonald BoellaardChantal RothEmma R MulderHenk M W VerheulCatharina Willemien Menke-van der Houven van OordtPublished in: PloS one (2016)
ClinicalTrials.gov NCT01691391.